A review on S100 proteins in the liver
Non-alcoholic fatty liver disease is a very frequent and slow progressing disease which can eventually give rise to the development of hepatocellular carcinoma. The lack of drugs to treat fatty liver disease or hepatocellular carcinoma led researchers from Prof. Michelangelo Foti’s laboratory to review the role of proteins from the S100 family.
Interested to learn more ?
To find out what is known and unknown about the role of S100 proteins in metabolic liver diseases as well as their clinical relevance as non-invasive biomarkers, download their recent review published in the International Journal of Molecular Sciences.
20 Oct 2022